[Diagnosis of autonomic disorders in Parkinson's disease].

Wiad Lek

Klinika Neurologii Wydziału Nauki O Zdrowiu, Warszawski Uniwersytet Medyczny, Warszawa, Polska.

Published: August 2020

Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder, characterized by motor and non-motor symptoms. Among non-motor symptoms we distinguish psychotic disorders, memory disorders, autonomic disorders. The aim: In this article, we want to draw attention to the most common symptoms of dysautonomy in Parkinson's disease, and the methods of their assessmen and therapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

autonomic disorders
8
parkinson's disease
8
non-motor symptoms
8
[diagnosis autonomic
4
disorders
4
disorders parkinson's
4
parkinson's disease]
4
disease] idiopathic
4
idiopathic parkinson's
4
disease neurodegenerative
4

Similar Publications

Crohn's disease, irritable bowel syndrome, and chronic fatigue: the importance of communication and symptom management-a case report.

J Med Case Rep

January 2025

Center for Complementary Medicine, Department of Internal Medicine II, Faculty of Medicine, Medical Center - University of Freiburg, University of Freiburg, 79106, Freiburg, Germany.

Background: Crohn's disease and irritable bowel syndrome may both cause abdominal pain and diarrhea. Irritable bowel syndrome not only is an important differential diagnosis for Crohn's disease but also occurs in one out of three patients with Crohn's disease in remission in parallel. If not adequately diagnosed and treated, additional functional symptoms such as fatigue and/or muscle pain may develop, indicating a more severe course.

View Article and Find Full Text PDF

Background And Objectives: The Chordate System administers kinetic oscillation stimulation (K.O.S) into the nasal cavity thereby potentially modulating the activity of trigemino-autonomic reflex.

View Article and Find Full Text PDF

Background: Amyloid and alpha synuclein proteins are brain biomarkers of different neurodegenerative diseases, many years before symptoms. We have shown that imaging dye-free with polarized light makes retinal amyloid deposits visible as a biomarker, in the brain, of amyloid and Alzheimer's disease (AD) severity. Here, we extend to presumed retinal alpha synuclein deposits in those with brain pathology consistent with alpha synuclein.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!